search icon

    Market Snapshot

    blog search icon

    ReShape Lifesciences Inc. Stock Profile, Price, History

    ReShape Lifesciences Inc.

    (NASDAQ:RSLS)

    $7.87

    -0.30 (-3.67%)

    At Close: 4:00 PM

    $8

    -0.17 (-2.08%)

    Pre Market: 4:06 AM

    ReShape Lifesciences Inc.

    • 1D
    • 5D
    • 1M
    • 3M
    • 6M
    • 1Y
    • YTD
    • All

    RSLS Stock Price Today

    ReShape Lifesciences Inc. (RSLS) stock declined over -3.67% intraday to trade at $7.87 a share on NASDAQ. The stock opened with a gain of 2.94% at $8.41 and touched an intraday high of $8.41, falling -3.67% against the last close of $8.17. The ReShape Lifesciences Inc. in stock market went to a low of $7.65 during the session.

    Stock Snapshot

    $8.17

    Prev. Close

    4.01 Million

    Market Cap

    $7.65

    Day Low

    $8.41

    Open

    480 Thousands

    Number of Shares

    $8.41

    Day High

    -

    P/E ratio

    -100.65

    EPS (TTM)

    0.51

    Cash Flow per Share

    4.31

    Free Float in %

    2.35

    Book Value

    32,093

    Volume

    Contact Details

    1001 Calle Amanecer
    San Clemente, CA 92673
    United States

    Website:https://www.reshapelifesciences.com

    Contact #:949 429 6680

    Company Information

    Employees47

    Beta-0.04

    Sales or Revenue$12.18 Million

    5Y Sales Change32.00%

    Fiscal Year EndsDec. 2021

    SectorHealth Care

    IndustryHealth Care Equipment

    About Company

    ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

    Frequently Asked Questions

    icon

    What is the current ReShape Lifesciences Inc. (RSLS) stock price?

    ReShape Lifesciences Inc. (NASDAQ: RSLS) stock price is $7.87 in the last trading session. During the trading session, RSLS stock reached the peak price of $8.41 while $7.65 was the lowest point it dropped to. The percentage change in RSLS stock occurred in the recent session was -3.67% while the dollar amount for the price change in RSLS stock was -$0.3.

    icon

    RSLS's industry and sector of operation?

    The NASDAQ listed RSLS is part of Health Care Equipment industry that operates in the broader Health Care sector. ReShape Lifesciences Inc. , a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.

    icon

    Who are the executives of RSLS?

    Mr. Thomas Stankovich
    Sr. VP of Fin., CFO, Interim CEO & Interim Pres
    Dr. Rajesh Nihalani
    Chief Technology Officer & Bus. Devel.
    Dr. Dov Gal D.V.M., DVM, M.B.A., MBA
    VP of Regulatory & Clinical Affairs and Compliance Officer
    Mr. Michael Bordainick
    Sr. VP of Commercial Operations

    icon

    How RSLS did perform over past 52-week?

    RSLS's closing price is 0.46% higher than its 52-week low of $5.4 where as its distance from 52-week high of $77 is -0.90%.

    icon

    How many employees does RSLS have?

    Number of RSLS employees currently stands at 47. RSLS operates from 1001 Calle Amanecer, San Clemente, CA 92673, United States.

    icon

    Link for RSLS official website?

    Official Website of RSLS is: https://www.reshapelifesciences.com

    icon

    How do I contact RSLS?

    RSLS could be contacted at phone #949 429 6680 and can also be accessed through its website. RSLS operates from 1001 Calle Amanecer, San Clemente, CA 92673, United States.

    icon

    How many shares of RSLS are traded daily?

    RSLS stock volume for the day was 32,093 shares. The average number of RSLS shares traded daily for last 3 months was 260.4 Thousands.

    icon

    What is the market cap of RSLS currently?

    The market value of RSLS currently stands at $4.01 Million with its latest stock price at $7.87 and 480 Thousands of its shares outstanding.